AI's Promise in Pharma: A Reality Check
1 min read
AI for Software Engineering (Copilots, SDLC, Testing)
-/5
In short
- Let’s be clear: AI is revolutionizing manufacturing and back-office operations in pharma, saving billions.
- Eli Lilly's digital chief admits it — AI is failing where it was hyped the most.
- This is a wake-up call for the industry.
Let’s be clear: AI is revolutionizing manufacturing and back-office operations in pharma, saving billions. But when it comes to drug discovery? It's a different story. Eli Lilly's digital chief admits it — AI is failing where it was hyped the most. This is a wake-up call for the industry. If you ignore this, you lose time. The hype around AI in labs has not translated into results. Why does this matter? Because the future of drug discovery hangs in the balance. Companies that cling to outdated methods will fall behind. It’s time to face the truth: AI is not the magic bullet we were promised. The game is changing, and only those who adapt will thrive. Don't get left behind in the dust of innovation.
Source:
-
AI is saving pharma billions in manufacturing and back-office work, just not in the lab — The Decoder (EN-US)